BioArctic receives new drug substance patent in the US for ABBV-0805 against Parkinson’s disease
Stockholm, May 6, 2022 – BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announced today that the US Patent and Trademark Office (USPTO) has granted a new ...